Delivery Order SPE2DB22D2211-SPE2DB25FSBXT
- Not listed
- The U.S. Defense Logistics Agency (DLA) awarded a $1,508.67 firm-fixed-price delivery order to Amerisourcebergen Drug Corp's Corporate Office Division for the supply of 4565535452 VARENICLINE 1 MG TABLET 56S. This order is part of a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999 between Amerisourcebergen and the DLA Troop Support Medical, which provides a comprehensive range of pharmaceutical and medical supplies to support military treatment programs and facilities...
- This federal contract award from the Defense Logistics Agency (DLA) is to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,963.85 firm fixed-price delivery order is for the supply of 56 tablets of the drug Varenicline 1 mg. The contract has an ultimate completion date of May 30, 2024. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle...
- This is a federal contract award from the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Varenicline 1 mg tablets. The contract, valued at $1,806.76, is a delivery order under an Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA, which is valued at $999,999,999 and runs through November 2026. This IDC serves as a primary vehicle for providing a comprehensive range of pharmaceutical...
- The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to AmerisourceBergen Drug Corp, a leading pharmaceutical distribution company, to supply the U.S. Department of Defense with varenicline 0.5 mg tablets. The contract has a ceiling value of $2,522.62 and a period of performance through March 15, 2024. This delivery order is part of a larger indefinite delivery contract (IDC) awarded solely to AmerisourceBergen Drug Corp, with a potential value of $999,999,999.00...
- This is a $4,280.16 firm fixed-price delivery order contract awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency for the supply of Varenicline 1mg tablets. The contract has an ultimate completion date of July 12, 2025 and is not set aside. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract with the Defense Logistics Agency Troop Support Medical, which provides a comprehensive global pharmaceutical support vehicle to...
- This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Varenicline 1 mg tablets. The contract has a ceiling value of $1,242.50 and a period of performance through January 10, 2025. The award is not designated as a set-aside contract. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) valued at $999,999,999 with the DLA Troop Support Medical, which serves as...
- The Defense Logistics Agency Troop Support Medical awarded a $2,431.57 firm fixed price delivery order to Amerisourcebergen Drug Corporation for 56 tablets of 1 mg varenicline under contract number 4561501889. The delivery order is to supply pharmaceutical products and has a period of performance from July 14, 2023 through July 17, 2023. Amerisourcebergen Drug Corporation will fulfill the order from its facility located in Conshohocken, Pennsylvania. No subcontractors or set aside designations...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp for the supply of 56 tablets of Varenicline 1 mg, a prescription medication. The contract has a firm fixed price of $2,809.24 and a completion date of August 12, 2024. AmerisourceBergen, a major pharmaceutical distributor, has been awarded this contract as part of its broader federal contracting activities with the DLA and other agencies. The company holds significant Indefinite...
- This is a Delivery Order award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) for the supply of 4,560,593,680 units of Varenicline 0.5 mg tablets. The contract has a Firm Fixed Price ceiling value of $3,381.47 and an ultimate completion date of April 17, 2023. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026, which...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,137.58 firm fixed-price delivery order is for the supply of 56 count tablets of the medication varenicline, with an ultimate completion date of October 13, 2022. The contract does not have a set-aside designation, indicating open competition. AmerisourceBergen holds a significant $999,999,999 Indefinite...
- SPE2DB22D2211Indefinite Delivery Contract
- SPE2DB22D2211-SPE2DB25FSBXTDelivery Order
The Defense Logistics Agency awarded a $1,007.15 delivery order to AmerisourceBergen Drug Corp on July 31, 2025, for the supply of Varenicline 1 mg tablets (56-count packages). This contract represents a firm fixed-price delivery order with an ultimate completion date of August 1, 2025, and carries no set-aside designation, indicating it was competitively awarded. The pharmaceutical product will be delivered to Conshohocken, Pennsylvania, the company's corporate headquarters location. This delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which is valued at $999,999,999.00 and extends through December 2026. As a major pharmaceutical distributor and critical federal medical procurement vendor, AmerisourceBergen Drug Corp supplies a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs and other government healthcare systems. The company's extensive contract portfolio with the DLA demonstrates its established capability to fulfill federal medical supply requirements across multiple therapeutic domains and geographic regions.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.0k | 7/31/25 |